Skip to main content

UBS Group AG

Position in ERNA — Ernexa Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in ERNA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,246
+$3,526 QoQ
Shares Held
849
+3437.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ERNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ERNA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,246 21,233
2025-12-31 $720 600
2025-06-30 $1,008 548
2025-03-31 $2,245 12,473
2024-12-31 $4,888 16,857
2024-09-30 $87,801 83,620
2024-03-31 $1,778 741
2023-09-30 $228 105
2023-03-31 $13,137 3,864
2020-12-31 NTN 1,401
2020-09-30 NTN 30
2020-06-30 NTN 654
2020-03-31 NTN 500